CD4 and neoplasm: As illustrated in Figure 5A, treatment with SDFZ‐8 resulted in a more significant increase in tumor‐infiltrating lymphocytes (TILs) than SAHA, particularly in the populations of CD4+ T cells and CD8+ T cells.